Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches

by Elena Nicod, Amanda Whittal, Michael Drummond, Karen Facey
Published 2020-07-01

Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?

by Claudio Jommi, Antonio Addis, Nello Martini, Elena Nicod, Marcello Pani, Annalisa Scopinaro, Sabine Vogler
Published 2021-08-01